CVS Health Corporation (CVS)
| Market Cap | 80.24B |
| Revenue (ttm) | 376.74B |
| Net Income (ttm) | 5.28B |
| Shares Out | 1.27B |
| EPS (ttm) | 4.19 |
| PE Ratio | 15.14 |
| Forward PE | 10.23 |
| Dividend | $2.66 (4.19%) |
| Ex-Dividend Date | Apr 22, 2025 |
| Volume | 10,593,027 |
| Open | 65.66 |
| Previous Close | 66.97 |
| Day's Range | 63.46 - 66.47 |
| 52-Week Range | 43.56 - 72.51 |
| Beta | 0.60 |
| Analysts | Buy |
| Price Target | 75.33 (+18.76%) |
| Earnings Date | May 1, 2025 |
About CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $75.33, which is an increase of 18.76% from the latest price.
News
CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced
CVS Health has shown impressive year-to-date performance, driven by strong Q1 results and strategic shifts in its business model. I reiterate a buy rating on CVS due to its low valuation, mixed techni...
CVS Health: Firing On All Cylinders, Thanks To The Promising Reversal
CVS' turnaround may be here, given the seemingly stabilizing medical cost trends as similarly reported by its peers, with it triggering the moderating Medical Benefit Ratio. This is despite the stable...
3 Ideal Buys From 63 May Fortune 500 Industry Leaders
The June/July 2024 Fortune Magazine revealed 500 biggest U.S. companies by-revenue and profits. Arnold-research focused on those industry-leaders using YCharts 5/7/25 data of Profits from 63. 63 Fortu...
CVS Backs Health-Tech Firm Kouper's $10 Million Fundraise
Health technology platform Kouper has emerged from stealth after raising $10 million. The company announced the new financing — from investors including General Catalyst, 25Madison and CVS Health Vent...
Healthy Returns: Novo Nordisk's Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Eli Lilly won't lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.
Build A 12%+ Yield On Cost By 2035 With May's Top 10 High-Yield Picks
In this article, I present 10 attractive high-yield investment options for this month of May 2025, which not only offer dividend income but also potential for dividend growth. The selection process in...
Activist investor Glenview Capital reduces stake in CVS Health
Activist investor Glenview Capital said on Tuesday it reduced its holdings in CVS Health by 3.75 million shares after the insurer posted "healthy" first-quarter results and raised annual forecast.
Glenview Capital Issues Statement on CVS Health
NEW YORK , May 6, 2025 /PRNewswire/ -- One year ago, we established a concentrated position in shares of CVS Health (NYSE: CVS). Since our purchases in May 2024, CVS shares have generated a total retu...
Breaking down 3 takeaways from healthcare earnings
Yahoo Finance Senior Health Reporter Anjalee Khemlani joins the Wealth team in breaking down the biggest themes she is seeing in the healthcare space from this earnings season, ranging from CVS Health...
DOJ Files Complaint Against Aetna, eHealth, Others, Alleging Medicare Advantage Kickbacks
The DOJ alleges in its complaint that CVS Health-unit Aetna, Elevance Health and Humana paid the kickbacks to brokers eHealth, GoHealth and SelectQuote in exchange for enrollments into the insurers' M...
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
Novo Nordisk A/S NVO announced that CVS Health Inc's CVS CVS Caremark, a Pharmacy Benefit Manager (PBM), has decided that Wegovy (semaglutide) injection 2.4 mg will soon be the preferred GLP-1 medicin...
CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone
Eli Lilly and Company's stock fell over 11% after CVS Caremark excluded Lilly's obesity drug Zepbound from its standard commercial formularies starting July 1, 2025. The market overreacted to CVS's ex...
CVS earnings: Things are finally clicking for the healthcare giant
CVS (CVS) stock jumped after beating first quarter earnings and revenue expectations. Jefferies Healthcare Services equity research analyst Brian Tanquilut explains how CVS's margin recovery and busin...
CVS Health: Why I'm Not Buying The Post-Earnings Share Buoyancy
CVS Health Corporation's Q1 2025 earnings show strong growth, with revenues up 7% YoY and adjusted EPS up 72%, but caution is advised for the long-term outlook. Despite positive quarterly results, CVS...
CVS Health (CVS) Q1 2025 Earnings Call Transcript
CVS Health Corporation (NYSE:CVS) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Company Participants David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President,...
CVS Health Partners With Wegovy Maker Novo Nordisk, Hikes 2025 Guidance
CVS Health Corp CVS reported first-quarter sales of $94.59 billion on Thursday, beating the consensus of $93.64 billion.
QCOM Earnings Sell-Off, CVS Turnaround Continues, LLY Disappoints
While Microsoft (MSFT) and Meta Platforms (META) shined in the Big Tech space, Diane King Hall turns to a mixed earnings picture elsewhere on Wall Street. CVS Health (CVS) posted an earnings beat, rai...
CVS Health Stock Surges as Q1 Results Handily Top Estimates
CVS Health (CVS) shares powered 9% higher before the bell Thursday after the pharmacy and healthcare giant's first-quarter results handily topped estimates.
CVS Health's stock surges toward a one-year high after an earnings triple play
Shares of CVS Health Corp. CVS jumped 6.6% toward a one-year high in premarket trading Thursday, after the healthcare-services company and drugstore chain scored a triple-play with its earnings report...
CVS Health raises annual profit forecast as turnaround gathers steam
CVS Health raised its full-year profit forecast on Thursday following strong performance across its businesses, signalling an early recovery after a series of troubles hit the healthcare conglomerate ...
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
CVS Health said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Under a new partnership between Caremark ...
CVS tops estimates, hikes guidance as insurance business shows some improvement
CVS Health reported first-quarter revenue and profit that topped estimates and hiked its guidance, as its troubled insurance business showed some improvement during the period. The company now expect...
CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business
The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.
CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE
First Quarter Financial Highlights Total revenues increased to $94.6 billion, up 7.0% compared to prior year GAAP diluted EPS of $1.41 and Adjusted EPS of $2.25 Generated cash flow from operations of ...
CVS Health Reports Earnings Thursday. The Stock Is Hot.
The stock has gained nearly 50% so far this year.